Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Cardiol ; 194: 17-26, 2023 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-36924641

RESUMO

Lower extremity endovascular intervention (LE-EVI) is gaining popularity as the primary treatment modality for patients with symptomatic peripheral artery disease refractory to noninvasive management. We examined the contemporary patterns of care, regional variation, and outcomes of ambulatory LE-EVI in the United States. The National Ambulatory Surgery Sample was analyzed to identify 266,563 records with peripheral artery disease and LE-EVI between January 1, 2016 and December 31, 2017. The mean age of the study cohort was 68.9 years and 40.5% were women. The majority of the endovascular interventions were performed at large (58.1%), urban teaching (64.1%), private not-for-profit (76.8%) centers, and the southern region accounted for most cases (43%). Periprocedural major adverse renal and cardiovascular events and other complications were 0.5% and 3.3%, respectively. Most patients (97.6%) were discharged home after the procedure. Age, female gender, uncontrolled hypertension, ischemic heart disease, heart failure, arrhythmia, chronic kidney disease, malnutrition, non-Medicare insurance, private for-profit, urban teaching facilities, and southern and midwest regions were associated with higher odds of major adverse renal and cardiovascular events. The mean charges per patient encounter were $56,500, with significant differences across various patient and facility characteristics. In conclusion, our study demonstrates the use, patterns of care, financial aspect, and overall safety of ambulatory LE-EVIs in a real-world setting.


Assuntos
Procedimentos Endovasculares , Doença Arterial Periférica , Humanos , Feminino , Estados Unidos/epidemiologia , Idoso , Masculino , Fatores de Risco , Resultado do Tratamento , Doença Arterial Periférica/epidemiologia , Doença Arterial Periférica/cirurgia , Doença Arterial Periférica/etiologia , Extremidade Inferior/irrigação sanguínea
2.
Cardiovasc Revasc Med ; 40S: 258-266, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-35410846

RESUMO

True trifurcation disease in left main coronary artery is an infrequent but highly complex substrate for percutaneous coronary intervention. Evidence for optimal stenting strategy for such anatomy is lacking. We describe a novel three-stent strategy using a combination of double-kissing crush (DK crush) and Culotte techniques in three patients. This approach, based on established bifurcation stenting techniques, appeared reproducible in all three cases.


Assuntos
Doença da Artéria Coronariana , Intervenção Coronária Percutânea , Angiografia Coronária , Doença da Artéria Coronariana/diagnóstico por imagem , Doença da Artéria Coronariana/terapia , Humanos , Intervenção Coronária Percutânea/efeitos adversos , Intervenção Coronária Percutânea/métodos , Stents , Fatores de Tempo , Resultado do Tratamento
4.
JACC Case Rep ; 4(3): 133-136, 2022 Feb 02.
Artigo em Inglês | MEDLINE | ID: mdl-35199003

RESUMO

Coronary artery perforation is a rare but serious complication during percutaneous coronary intervention. Distal or small vessel perforation is usually treated by coil, fat, or microsphere embolization. We describe 5 cases of distal coronary perforation that were managed successfully by a novel technique that uses absorbable sutures. (Level of Difficulty: Advanced.).

5.
Am J Cardiol ; 156: 129-131, 2021 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-34364657

RESUMO

COVID-19 vaccination was launched in the United States in mid-December 2020. There are limited data on the risk of thrombotic events related to COVID-19 vaccines. In conclusion, we report 2 cases of acute myocardial infarction with onset <24 hours after the first dose of a COVID-19 vaccine in patients presenting with shoulder pain.


Assuntos
Vacinas contra COVID-19/efeitos adversos , COVID-19/prevenção & controle , Infarto do Miocárdio/etiologia , SARS-CoV-2/imunologia , Vacinação/efeitos adversos , Adulto , Idoso , COVID-19/epidemiologia , Feminino , Seguimentos , Humanos , Masculino , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...